Latest news and press releases about Plus Therapeutics, Inc. (PSTV): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Plus Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, dedicated to the development, manufacturing, and market introduction of therapeutic solutions for cancer patients and individuals with other serious illnesses.
Price
| Price | $3.87 |
| Market Cap | $9M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 4.80 |
| EV / EBITDA | -1.74 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -560.21% |
| Return on Invested Capital | -317.58% |
| Return on Assets | -137.13% |
| Gross Margin | 61.53% |
| Operating Margin | -628.12% |
| Net Margin | -620.70% |
Related companies: ADTX · BXRXQ · EDSA · MTVA · PHIO · RKTO
Explore sector: Healthcare · Biotechnology
More sections of PSTV: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks